CE-CCMRA | DS-CCTA | p Value | |
---|---|---|---|
Patient-based analysis | n = 51 | n = 51 | |
Sensitivity | 93.5 (29/31) [77.2–98.9] | 93.5 (29/31) [77.2–98.9] | > 0.05 |
Specificity | 85.0 (17/20) [61.1–96.0] | 90.0 (18/20) [66.9–98.2] | > 0.05 |
PPV | 90.6 (29/32) [73.8–97.5] | 93.5 (29/31) [77.2–98.9] | > 0.05 |
NPV | 89.4 (17/19) [65.5–98.2] | 90.0 (18/20) [66.9–98.2] | > 0.05 |
Vessel-based analysis | n = 153 | n = 153 | |
Sensitivity | 93.0 (53/57) [82.2–97.7] | 94.7 (54/57) [84.5–98.6] | > 0.05 |
Specificity | 89.6 (86/96) [81.3–94.6] | 90.7 (87/96) [82.5–95.4] | > 0.05 |
PPV | 84.1 (53/63) [72.3–91.7] | 85.7 (54/63)[74.1–92.9] | > 0.05 |
NPV | 95.6 (86/90) [88.4–98.6] | 96.7 (87/90) [89.9–99.1] | > 0.05 |